Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000930413-17-002293
Filing Date
2017-06-06
Accepted
2017-06-06 18:42:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 45027
2 GRAPHIC image_002.jpg GRAPHIC 34595
  Complete submission text file 0000930413-17-002293.txt   93476
Mailing Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5
Business Address 4150 ST CATHERINE STREET WEST SUITE 550 MONTREAL A8 H3Z 2Y5 (514) 940-3600
Clementia Pharmaceuticals Inc. (Filer) CIK: 0001647320 (see all company filings)

EIN.: 981128564 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations